DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.

Clinical trial NCT06820255 · RECRUITING

Trial details

NCT number: NCT06820255
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable Upper Tract Urothelial Cancer

Start date: 2025-01-07
Primary completion: 2026-01-07
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.